Basic information |  | HA (n = 45) | PFNA (n = 54) | Statistical analyses | P value |
---|---|---|---|---|---|
Gender | Male | 15 (33.33%) | 16 (29.63%) | χ2 = 0.157 | 0.69 |
Female | 30 (66.67%) | 38 (70.37%) | Â | Â | |
Age at the time of injury (years) |  | 81.78 ± 8.18 | 80.52 ± 8.42 | T = 0.7506 | 0.46 |
Age at last follow-up (years) |  | 82.60 ± 8.21 | 82.00 ± 8.46 | T = 0.3694 | 0.71 |
Side of fracture | Left | 22 (48.89%) | 28 (51.85%) | χ2 = 0.086 | 0.77 |
Right | 23 (51.11%) | 26 (48.45%) | Â | Â | |
AO classification | A1.1 | 11 (24.4%) | 9 (16.67%) | χ2 = 7.458 | 0.28 |
A1.2 | 16 (35.56%) | 11 (20.37%) | Â | Â | |
A1.3 | 7 (15.56%) | 13 (24.07%) | Â | Â | |
A2.1 | 7 (15.56%) | 11 (20.37%) | Â | Â | |
A2.2 | 0 (0%) | 4 (7.41%) | Â | Â | |
A2.3 | 0 (0%) | 0 (0%) | Â | Â | |
A3.1 | 2 (4.44%) | 3 (5.56%) | Â | Â | |
A3.2 | 2 (4.44%) | 3 (5.56%) | Â | Â | |
A3.3 | 0 (0%) | 0 (0%) | Â | Â | |
ASA grade | I | 6 (13.33%) | 11 (20.37%) | χ2 = 1.313 | 0.73 |
II | 29 (64.44%) | 33 (61.11%) | Â | Â | |
III | 8 (17.78%) | 9 (16.67%) | Â | Â | |
IV | 2 (4.44%) | 1 (1.85%) | Â | Â | |
Singh index | I | 1 (2.22%) | 1 (1.85%) | χ2 = 5.221 | 0.27 |
II | 5 (11.11%) | 16 (18.52%) | Â | Â | |
III | 13 (28.89%) | 12 (22.22%) | Â | Â | |
IV | 14 (31.11%) | 12 (22.22%) | Â | Â | |
V | 12 (26.67%) | 13 (24.07%) | Â | Â | |
Comorbidities | Hypertension | 18 (40.00%) | 24 (44.44%) | χ2 = 1.198 | 0.66 |
Cardiovascular and cerebrovascular disease | 20 (44.44%) | 17 (31.48%) | χ2 = 1.762 | 0.18 | |
Diabetes mellitus | 12 (26.67%) | 11 (20.37%) | χ2 = 0.546 | 0.46 | |
Chronic respiratory disease | 12 (28.89%) | 8 (14.81%) | χ2 = 2.909 | 0.09 | |
Neurological disease | 9 (20.00%) | 12 (22.22%) | χ2 = 0.073 | 0.79 | |
Thrombogenesis | 6 (13.33%) | 4 (7.41%) | χ2 = 0.949 | 0.33 | |
Urological disease | 1 (2.22%) | 4 (7.41%) | χ2 = 1.376 | 0.24 |